Zepto Life Technology Introduces FungiFlex® Pneumocystis jirovecii and FungiFlex® Mold Plus
New targeted plasma cfDNA liquid biopsy testing options expand the FungiFlex ®menu, allowing clinicians to order targeted Pneumocystis jirovecii testing or combined mold and P. jirovecii detection based on the clinical question. ST. PAUL, Minn., July 15, 2026 /PRNewswire/ -- Zepto Life...
New targeted plasma cfDNA liquid biopsy testing options expand the FungiFlex ®menu, allowing clinicians to order targeted Pneumocystis jirovecii testing or combined mold and P. jirovecii detection based on the clinical question. ST. PAUL, Minn., July 15, 2026 /PRNewswire/ -- Zepto Life...
Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.